Ventas (NYSE:VTR) Posts Earnings Results, Misses Expectations By $0.85 EPS

Ventas (NYSE:VTR – Get Free Report) released its quarterly earnings results on Tuesday, October 27th. The real estate investment trust reported $0.13 earnings per share for the quarter, missing analysts’ consensus estimates of $0.98 by ($0.85), Zacks reports. The business had revenue of $1.83 billion for the quarter, compared to the consensus estimate of $1.77 billion. Ventas had a net margin of 3.86% and a return on equity of 1.86%. The business’s quarterly revenue was up 23.0% on a year-over-year basis. During the same period last year, the firm posted $0.88 EPS.

Ventas Price Performance

VTR stock traded down $0.71 on Friday, hitting $88.94. 2,226,914 shares of the company’s stock traded hands, compared to its average volume of 3,550,009. Ventas has a 1-year low of $73.82 and a 1-year high of $101.60. The stock has a market cap of $47.03 billion, a price-to-earnings ratio of 167.81, a P/E/G ratio of 3.67 and a beta of 0.77. The stock has a fifty day moving average of $86.40 and a 200-day moving average of $87.03. The company has a current ratio of 0.43, a quick ratio of 0.43 and a debt-to-equity ratio of 0.78.

Ventas Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, October 15th. Investors of record on Wednesday, September 30th were issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date was Wednesday, September 30th. Ventas’s payout ratio is presently 392.45%.

Analyst Ratings Changes

VTR has been the topic of several analyst reports. BMO Capital Markets raised their target price on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a research report on Tuesday, August 11th. BNP Paribas Exane increased their price target on Ventas from $93.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 30th. JPMorgan Chase & Co. lifted their price target on Ventas from $94.00 to $104.00 and gave the company an “overweight” rating in a research report on Wednesday, September 2nd. UBS Group boosted their price objective on Ventas from $90.00 to $99.00 and gave the stock a “neutral” rating in a research note on Wednesday. Finally, Cantor Fitzgerald dropped their price objective on Ventas from $102.00 to $95.00 and set an “overweight” rating on the stock in a research note on Thursday, October 29th. Seventeen investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat, Ventas presently has an average rating of “Moderate Buy” and an average target price of $99.68.

Check Out Our Latest Stock Analysis on VTR

About Ventas

(Get Free Report)

Ventas, Inc. is a real estate investment trust focused on properties and services that support the health care and senior living sectors. Its portfolio includes senior housing communities, outpatient medical buildings, and research and life science facilities. The company owns and invests in properties across the United States, Canada, and the United Kingdom. Many of its communities and facilities are operated by health care and senior living providers, while Ventas provides real estate capital and asset management.

Featured Stories

Earnings History for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.